Webull Connect is designed to provide Australian financial advisers access to multi-currency Australian, U.S. and Hong Kong markets from a single platform, enabling trade execution and portfolio management across multiple accounts. The launch marks Webull's entry into the Australian wealth management segment. Webull's high-tech, low-fee platform supports such advisers wishing to grow their margins while maintaining competitive pricing for their underlying clients. SYDNEY, Feb. 18, 2026 -- Webull Securities (Australia) Pty Ltd ("Webull Australia"), a subsidiar
MELBOURNE, Australia and INDIANAPOLIS, Feb. 18, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has submitted a marketing authorization application (MAA) in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its glioma (brain cancer) imaging candidate. Telix has been preparing the European and U.S. regulatory packages for TLX101-Px concurrently, bringing forward the European submission to meet an agreed filing date while aligning with aspects of the U.S. Food and Drug Administration (FDA) pac
SAN JOSE, Calif., Feb. 18, 2026 -- AnChain.AI, the award winning AI-powered digital asset risk and security company, today announced a strategic partnership with NUVA, the chain-agnostic marketplace providing permissionless exposure to institutional-grade real-world assets (RWAs) from leading issuers through blockchain-powered vaults, empowering users with tokens that are liquid and composable. The collaboration integrates AnChain.AI's comprehensive suite of blockchain security and compliance solutions with NUVA. This partnership is designed to instill a new level of trust and regulato
[ 메디채널 황정호 기자 ] Seasoned executive brings nearly 30 years of vendor finance expertise to strengthen Valiant's market position SAN FRANCISCO, Feb. 18, 2026 -- Australian fintech Valiant Finance has appointed Joe Iavarone as North American President (Sales & Marketing), a veteran with nearly three decades of vendor finance experience, to lead Valiant's US market growth. The appointment marks a significant milestone for Valiant, which has facilitated more than $3 billion in loans and has established itself as a leader in SMB financing software. Valiant's US expansion i
BUDAPEST, Hungary, Feb. 18, 2026 -- The International Teqball Federation (FITEQ) is proud to announce another historic milestone for the sport: Teqball has officially been included as a medal sport at the 20th Asian Games in Aichi–Nagoya 2026. This recognition marks one of the most significant steps forward in Teqball's continental and global development within the international multisport landscape. Teqball's inclusion in major Asian events reflects the rapid and undeniable growth of the sport across the continent. Earlier this year, Teqball made its debut as a medal sport at
National Comprehensive Cancer Network publishes new guidelines for Pediatric Soft Tissue Sarcomas, focused on rhabdomyosarcoma. PLYMOUTH MEETING, Pa., Feb. 18, 2026 -- The National Comprehensive Cancer Network® (NCCN®) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Soft Tissue Sarcomas. This is the 7th NCCN Guidelines® for a pediatric cancer, expanding the overall library to cover 91 topics in cancer care. The guidelines present the latest evidence-based, expert consensus-driven recommendations for nearly every
MURRIETA, Calif., Feb. 17, 2026 -- Copan Group announced today that PhenoMATRIX®, its automated image assessment software used with WASPLab® full laboratory automation, received FDA 510(k) clearance as a Class II device in the United States. PhenoMATRIX is an in vitro diagnostic software that uses artificial intelligence with laboratory-defined rules and clinical information to automatically sort images of bacterial culture plates, helping laboratory professionals streamline plate review while maintaining expert oversight. The cleared intended use include
무리에타, 캘리포니아, 2026년 2월 17일 -- 2월 17일 코판 그룹(Copan Group)이 자사의 전면 검사실 자동화 솔루션인 WASPLab®과 함께 사용되는 자동 이미지 판독 소프트웨어 PhenoMATRIX®가 미국에서 2등급 의료기기로 FDA 510(k) 승인을 획득했다고 발표했다. PhenoMATRIX는 인공지능(AI)과 검사실에서 정의한 규칙 및 임상 정보를 결합해 세균 배양 플레이트 이미지를 자동으로 분류하는 체외 진단 소프트웨어로, 검사실 전문가는 이 소프트웨어를 활용해 전문적 감독을 유지하면서 효율적으로 플레이트를 판독할 수 있다. 이번에 승인된 사용 목적에는 혈액 한천, 초콜릿 한천, 맥콘키 한천(MacConkey agar) 및 CHROMagar orientation 배양 배지 플레이트가 포함된다. 이를 통해 미생물 성장 감지, 집락 수 추정, 표현형 집락 특성에 따른 분리균 감별을 통해 반정량적 및 정성적 이미지 기반 분석을 수행할 수 있다. 코판 다이애그노스틱스(Copan Diagnostics)의 파브리치오 마조키(Fabrizio Mazzocchi)
NEW YORK, Feb. 17, 2026 -- As artificial intelligence reshapes the 21st century, Student B Press has launched Animal Intelligence, a cross-genre publishing project that revives animal fables and editorial cartoons as tools for reflection in the AI era. Throughout history, moments of technological and social upheaval have given rise to allegory and satire—forms that return when language struggles to keep pace with change. Animal Intelligence reimagines these traditions through a contemporary publishing universe that blends philosophical fables and cartoons. Observing Huma
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 17, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. USA TODAY Co. Celebrates Its Rebrand at NYSE Ashley Mastronardi delivers the pre-market update on February 17th Stocks are down Tuesday morning ahead of a shortened trading week after markets were closed yesterday for Presidents Day. Leaders from Payments platfor